LUMICKS (IEU LS)

Projektträger – zwischengeschaltetes Finanzinstitut

LUMICKS TECHNOLOGIES BV

Ort

• Niederlande

Beschreibung

The project will support the Research and Development investments (RDI) of Lumicks into development of next generation cell avidity and dynamic single-molecule instruments, allowing real-time analysis of molecular and cellular mechanisms and interactions. With large applications in fundamental and applied research, the new instruments can speed up and enhance success rates in drug discovery and development.

Ziele

The project supports the continued development, manufacturing scale-up and market access of Cellular Avidity and Dynamic Single Molecule instruments. These tools allow research institutions, biotech and pharma companies to conduct a more efficient rational drug design and development, ultimately giving more reliable in vitro results before entering in vivo models (clinical stage).

Sektor(en)

• Industrie - Verarbeitendes Gewerbe/Herstellung von Waren
• Dienstleistungen - Erbringung von Freiberuflichen, Wissenschaftlichen und Technischen Dienstleistungen

Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

EUR 20 million

Gesamtkosten (voraussichtlicher Betrag)

EUR 46 million

Umweltaspekte

The project concerns investments in research and development activities carried out by the promoter and its partners in existing facilities without changing their already authorised scope. The related RDI activities do not fall under either Annex I or Annex II of the Environmental Impact Assessment (EIA) Directive 2011/92/EU (amended by Directive 2014/52/EU). Full environmental details will be verified during appraisal.

Auftragsvergabe

The EIB requires that all project contracts are procured in accordance with the applicable EU procurement legislation.

Projektstatus

Unterzeichnet - 10/10/2024